SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-16-016451
Filing Date
2016-04-21
Accepted
2016-04-21 16:11:48
Documents
4
Period of Report
2016-04-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ctmx-8k_20160421.htm 8-K 54134
2 EX-99.1 ctmx-ex991_6.htm EX-99.1 28932
3 GRAPHIC gggdaj3xidgv000002.jpg GRAPHIC 255348
4 GRAPHIC gggdaj3xidgv000001.jpg GRAPHIC 4992
  Complete submission text file 0001564590-16-016451.txt   443093
Mailing Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37587 | Film No.: 161584178
SIC: 2834 Pharmaceutical Preparations